tetano
Editor, Senior Moderator
Perfusion
. 2023 Dec 29:2676591231224645.
doi: 10.1177/02676591231224645. Online ahead of print. Outcomes of COVID-19 patients undergoing extracorporeal membrane oxygenation: A systematic review and meta-Analysis
Shouliang Jiang[SUP] 1 [/SUP], Ping Yan[SUP] 2 [/SUP], Zhongyang Ma[SUP] 1 [/SUP], Juan Liang[SUP] 1 [/SUP], Yong Hu[SUP] 1 [/SUP], Jun Tang[SUP] 1 [/SUP]
Affiliations
Background: The Coronavirus Disease 2019 (COVID-19) pandemic has been ongoing for over 3 years, during which numerous clinical and experimental studies have been conducted. The objective of this systematic review and meta-analysis was to assess the survival probability and complications of COVID-19 patients receiving extracorporeal membrane oxygenation (ECMO).
Methods: We searched the databases by using Population-Intervention-Comparison-Outcome-Study Design (PICOS). We conducted a search of the PubMed, Web of Science, and EMBASE databases to retrieve studies published until December 10, 2022. A random-effects meta-analysis, subgroup analysis, and assessed the studies using the Newcastle-Ottawa Scale score. The results were presented as pooled morbidity with 95% confidence intervals.
Results: The study was conducted on 19 studies that enrolled a total of 1494 patients, and the results showed a pooled survival probability of 66.0%. The pooled morbidity for intracranial hemorrhage was 8.7%, intracranial thrombosis 7.0%, pneumothorax 9.0%, pulmonary embolism 11.0%, pulmonary hemorrhage 9.0%, heart failure 14.0%, liver failure 13.0%, renal injury 44.0%, gastrointestinal hemorrhage 6.0%, gastrointestinal ischemia 6.0% and venous thrombosis 31.0%.
Conclusion: This systematic review and meta-analysis of observational studies focused on the survival probability and complications of COVID-19 patients undergoing ECMO, which are significant in evaluating the use of ECMO in COVID-19 patients and provide a basis for further research.
Trial registration: Our study was registered on PROSPERO with registration number CRD42022382555.
Keywords: COVID-19; complication; extracorporeal membrane oxygenation; outcomes; randomized study.
. 2023 Dec 29:2676591231224645.
doi: 10.1177/02676591231224645. Online ahead of print. Outcomes of COVID-19 patients undergoing extracorporeal membrane oxygenation: A systematic review and meta-Analysis
Shouliang Jiang[SUP] 1 [/SUP], Ping Yan[SUP] 2 [/SUP], Zhongyang Ma[SUP] 1 [/SUP], Juan Liang[SUP] 1 [/SUP], Yong Hu[SUP] 1 [/SUP], Jun Tang[SUP] 1 [/SUP]
Affiliations
- PMID: 38158713
- DOI: 10.1177/02676591231224645
Background: The Coronavirus Disease 2019 (COVID-19) pandemic has been ongoing for over 3 years, during which numerous clinical and experimental studies have been conducted. The objective of this systematic review and meta-analysis was to assess the survival probability and complications of COVID-19 patients receiving extracorporeal membrane oxygenation (ECMO).
Methods: We searched the databases by using Population-Intervention-Comparison-Outcome-Study Design (PICOS). We conducted a search of the PubMed, Web of Science, and EMBASE databases to retrieve studies published until December 10, 2022. A random-effects meta-analysis, subgroup analysis, and assessed the studies using the Newcastle-Ottawa Scale score. The results were presented as pooled morbidity with 95% confidence intervals.
Results: The study was conducted on 19 studies that enrolled a total of 1494 patients, and the results showed a pooled survival probability of 66.0%. The pooled morbidity for intracranial hemorrhage was 8.7%, intracranial thrombosis 7.0%, pneumothorax 9.0%, pulmonary embolism 11.0%, pulmonary hemorrhage 9.0%, heart failure 14.0%, liver failure 13.0%, renal injury 44.0%, gastrointestinal hemorrhage 6.0%, gastrointestinal ischemia 6.0% and venous thrombosis 31.0%.
Conclusion: This systematic review and meta-analysis of observational studies focused on the survival probability and complications of COVID-19 patients undergoing ECMO, which are significant in evaluating the use of ECMO in COVID-19 patients and provide a basis for further research.
Trial registration: Our study was registered on PROSPERO with registration number CRD42022382555.
Keywords: COVID-19; complication; extracorporeal membrane oxygenation; outcomes; randomized study.